Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-23

Clinical Trial Update: The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis Patients [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial assessed whether pomegranate juice can reduce oxidative stress in patients with end-stage renal disease undergoing hemodialys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomegranate juice

Snippet

Sponsor: Western Galilee Hospital-Nahariya | Conditions: End Stage Renal Disease, Hemodialysis | Phase 3 | Status: COMPLETED